Jalra-M 50mg/500mg Tablet

Description

About Jalra-M 50mg/500mg Tablet

Jalra-M 50mg/500mg Tablet is an oral anti-diabetic medicine used to manage Type 2 Diabetes Mellitus in adults.
It is prescribed when diet, exercise, and monotherapy with either Vildagliptin or Metformin are inadequate for blood glucose control.
This dual-action combination helps control both fasting and postprandial blood sugar levels, improving overall glycemic control.

---

How It Works

• Vildagliptin (50mg): A DPP-4 inhibitor that increases incretin hormones, promoting insulin release after meals and reducing glucagon secretion.

• Metformin (500mg): A biguanide that decreases glucose production in the liver and improves insulin sensitivity.

Together, they enhance insulin action, reduce hepatic glucose output, and help maintain stable blood sugar levels throughout the day.

---

Uses

• Management of Type 2 Diabetes Mellitus

• Controls fasting and post-meal (postprandial) glucose levels

• Reduces the risk of diabetes-related complications

---

Directions for Use

• Take the tablet twice daily, preferably with meals, to reduce stomach discomfort.

• Swallow whole; do not crush or chew.

• Maintain a balanced diet and regular physical activity alongside medication.

---

Side Effects

Common side effects may include:

• Nausea, vomiting, or stomach upset

• Diarrhea or bloating

• Headache

• Dizziness

• Mild hypoglycemia (especially when combined with other anti-diabetics)

Seek medical attention if you experience severe hypoglycemia, lactic acidosis, or allergic reactions.

---

Precautions

• Avoid alcohol, as it may increase the risk of lactic acidosis.

• Inform your doctor if you have kidney, liver, or heart problems.

• Not recommended during pregnancy or breastfeeding unless prescribed.

• Monitor blood glucose and HbA1c levels regularly.

• Take the medicine at the same times each day for consistent effect.